SECURITIES AND EXCHANGE COMMISSION
	Washington, D. C.  20549
	                                  

	FORM 10-Q

	QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarter Ended June 30, 1998  Commission File No. 2-82655

	             INTERWEST MEDICAL CORPORATION           
	(Exact name of registrant as specified in its charter)

           Oklahoma         	               75-1864474          
(State or other jurisdiction	 (I.R.S. Employer Identification No.)
of incorporation or organization)

	Arlington Heights Professional Office Building
	3221 Hulen Street, Suite C, Fort Worth, TX  76107-6193
	(Address of principal executive offices, zip code)

Registrant's telephone number, including area code: (817)731-2743

	                     Not Applicable                     
	(Former name, former address, and former fiscal year, if
	changed since last report)

Indicate by check mark whether the registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.  

Yes   X  				No       

	APPLICABLE ONLY TO ISSUERS INVOLVED IN
	BANKRUPTCY PROCEEDINGS DURING THE
	PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all 
documents and reports required to be filed by Sections 12, 13 or 
15(d) of the Securities Exchange Act of 1934 subsequent to the 
distribution of securities under a plan confirmed by a court.  

	(Not Applicable)

Yes    X 				No       

	(APPLICABLE TO CORPORATE ISSUERS)

Indicate the number of shares outstanding of each of the issuer's 
classes of common stock, as of the close of the period covered by 
this report.  16,541,661 shares of Common Stock, $0.001 Par 
Value.  



SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, 
the registrant has duly caused this report to be signed on its half 
by the undersigned thereunto duly authorized. 

INTERWEST MEDICAL CORPORATION



By:   		 
Arch B. Gilbert, President,
Chief Executive Officer,
Chief Financial Officer, and
Chief Accounting Officer

Date:	August 14, 1998




[ARTICLE]   5
				
[PERIOD-TYPE]   6-MOS   
[FISCAL-YEAR-END]               DEC-31-1997
[PERIOD-END]                    JUN-30-1998
[CASH]                              544,865 
[SECURITIES]                      2,825,164
[RECEIVABLES]                     2,498,327
[ALLOWANCES]                              0
[INVENTORY]                               0
[CURRENT-ASSETS]                  5,906,424
[PP&E]                            5,550,141
[DEPRECIATION]                    1,926,755
                    9,978,882
             1,885,529
[BONDS]                                   0
[COMMON]                             20,000
[PREFERRED-MANDATORY]                     0
[PREFERRED]                               0
[OTHER-SE]                        1,712,689
[TOTAL-LIABILITY-AND-EQUITY]      9,978,882
[SALES]                           2,685,805
[TOTAL-REVENUES]                  2,718,098
[CGS]                                     0
[TOTAL-COSTS]                     2,457,842
                          0
[LOSS-PROVISION]                          0
[INTEREST-EXPENSE]                   88,734
[INCOME-PRETAX]                     299,295
[INCOME-TAX]                              0 
[INCOME-CONTINUING]                 299,295
[DISCONTINUED]                            0
[EXTRAORDINARY]                           0
[CHANGES]                                 0
[NET-INCOME]                        299,295
[EPS-PRIMARY]                           .02
[EPS-DILUTED]                           .02